Latest Insider Transactions at Haemonetics Corp (HAE)
This section provides a real-time view of insider transactions for Haemonetics Corp (HAE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HAEMONETICS CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HAEMONETICS CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 05
2022
|
Robert E Abernathy Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,730
+13.26%
|
-
|
|
Jul 05
2022
|
Laurie A. Miller SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
42
-0.32%
|
$2,772
$66.18 P/Share
|
|
Jun 13
2022
|
Simon, Christopher President & CEO |
SELL
Open market or private sale
|
Direct |
1,148
-0.53%
|
$71,176
$62.6 P/Share
|
|
Jun 13
2022
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
277
-0.68%
|
$17,174
$62.6 P/Share
|
|
Jun 13
2022
|
Dan Goldstein VP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
42
-0.94%
|
$2,604
$62.6 P/Share
|
|
Jun 13
2022
|
Laurie A. Miller SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
30
-0.23%
|
$1,860
$62.6 P/Share
|
|
Jun 02
2022
|
Laurie A. Miller SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
198
-1.5%
|
$12,276
$62.69 P/Share
|
|
Jun 02
2022
|
Dan Goldstein VP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
249
-5.26%
|
$15,438
$62.69 P/Share
|
|
May 19
2022
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
3,258
-7.38%
|
$192,222
$59.1 P/Share
|
|
May 19
2022
|
Dan Goldstein VP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
134
-2.75%
|
$7,906
$59.1 P/Share
|
|
May 19
2022
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
1,384
-7.4%
|
$81,656
$59.1 P/Share
|
|
May 19
2022
|
Josep Llorens EVP, Global Manufacturing |
SELL
Open market or private sale
|
Direct |
1,418
-7.56%
|
$83,662
$59.1 P/Share
|
|
May 19
2022
|
Laurie A. Miller SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
91
-0.69%
|
$5,369
$59.1 P/Share
|
|
May 19
2022
|
Simon, Christopher President & CEO |
SELL
Open market or private sale
|
Direct |
2,496
-1.15%
|
$147,264
$59.1 P/Share
|
|
May 19
2022
|
Stewart W Strong President, Global Hospital |
SELL
Open market or private sale
|
Direct |
1,084
-6.44%
|
$63,956
$59.1 P/Share
|
|
May 16
2022
|
Simon, Christopher President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
26,041
+10.7%
|
-
|
|
May 16
2022
|
Simon, Christopher President & CEO |
SELL
Open market or private sale
|
Direct |
832
-0.43%
|
$46,592
$56.1 P/Share
|
|
May 16
2022
|
James D Arecca EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,774
+30.9%
|
-
|
|
May 16
2022
|
Michelle L Basil EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
6,076
+12.09%
|
-
|
|
May 16
2022
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
196
-0.51%
|
$10,976
$56.1 P/Share
|
|
May 16
2022
|
Dan Goldstein VP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
868
+15.12%
|
-
|
|
May 16
2022
|
Dan Goldstein VP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
50
-1.23%
|
$2,800
$56.1 P/Share
|
|
May 16
2022
|
Anila Lingamneni EVP, Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,340
+18.83%
|
-
|
|
May 16
2022
|
Josep Llorens EVP, Global Manufacturing |
BUY
Grant, award, or other acquisition
|
Direct |
4,340
+18.79%
|
-
|
|
May 16
2022
|
Josep Llorens EVP, Global Manufacturing |
SELL
Open market or private sale
|
Direct |
107
-0.74%
|
$5,992
$56.1 P/Share
|
|
May 16
2022
|
Laurie A. Miller SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
3,038
+18.63%
|
-
|
|
May 16
2022
|
Laurie A. Miller SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
31
-0.3%
|
$1,736
$56.1 P/Share
|
|
May 16
2022
|
Stewart W Strong President, Global Hospital |
BUY
Grant, award, or other acquisition
|
Direct |
4,123
+19.67%
|
-
|
|
May 02
2022
|
James D Arecca EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,902
+50.0%
|
-
|
|
Apr 18
2022
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
189
-1.33%
|
$10,584
$56.55 P/Share
|
|
Oct 25
2021
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
120
-0.31%
|
$8,520
$71.93 P/Share
|
|
Oct 25
2021
|
Stewart W Strong President, Global Hospital |
SELL
Open market or private sale
|
Direct |
75
-0.59%
|
$5,325
$71.93 P/Share
|
|
Sep 17
2021
|
Laurie A. Miller SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
2,848
+22.03%
|
-
|
|
Sep 07
2021
|
Josep Llorens EVP, Global Manufacturing |
SELL
Open market or private sale
|
Direct |
100
-0.68%
|
$6,400
$64.61 P/Share
|
|
Aug 23
2021
|
William P. Burke Mr. EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,667
-42.8%
|
$1,360,020
$60.51 P/Share
|
|
Aug 23
2021
|
William P. Burke Mr. EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,667
+19.52%
|
$838,679
$37.92 P/Share
|
|
Aug 06
2021
|
Lloyd Emerson Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,077
+50.0%
|
-
|
|
Aug 06
2021
|
Ellen M Zane Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,077
+24.43%
|
-
|
|
Aug 06
2021
|
Robert E Abernathy Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,077
+16.9%
|
-
|
|
Aug 06
2021
|
Catherine M Burzik Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,077
+15.47%
|
-
|
|
Aug 06
2021
|
Michael J Coyle Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,077
+35.72%
|
-
|
|
Aug 06
2021
|
Charles J Dockendorff Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,077
+10.81%
|
-
|
|
Aug 06
2021
|
Mark W Kroll Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,077
+12.51%
|
-
|
|
Aug 06
2021
|
Claire Pomeroy Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,077
+30.49%
|
-
|
|
Jul 01
2021
|
William P. Burke Mr. EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,293
-12.41%
|
$283,338
$66.6 P/Share
|
|
Jun 14
2021
|
Simon, Christopher President & CEO |
SELL
Open market or private sale
|
Direct |
1,200
-0.62%
|
$70,800
$59.87 P/Share
|
|
Jun 14
2021
|
William P. Burke Mr. EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
190
-0.55%
|
$11,210
$59.87 P/Share
|
|
Jun 14
2021
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
195
-0.51%
|
$11,505
$59.87 P/Share
|
|
Jun 14
2021
|
Dan Goldstein VP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
39
-0.95%
|
$2,301
$59.87 P/Share
|
|
Jun 07
2021
|
Simon, Christopher President & CEO |
SELL
Open market or private sale
|
Direct |
2,715
-1.39%
|
$149,325
$55.09 P/Share
|